Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 23 | 2024 | 994 | 3.780 |
Why?
|
| Brain Ischemia | 13 | 2023 | 401 | 3.500 |
Why?
|
| Endovascular Procedures | 10 | 2025 | 290 | 2.830 |
Why?
|
| Thrombectomy | 11 | 2025 | 190 | 2.220 |
Why?
|
| Thrombolytic Therapy | 8 | 2024 | 241 | 1.970 |
Why?
|
| Stents | 8 | 2024 | 412 | 1.350 |
Why?
|
| Fibrinolytic Agents | 8 | 2024 | 227 | 1.160 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2024 | 55 | 1.040 |
Why?
|
| Embolization, Therapeutic | 3 | 2024 | 265 | 1.010 |
Why?
|
| Carotid Arteries | 3 | 2024 | 135 | 0.930 |
Why?
|
| Triage | 1 | 2021 | 117 | 0.720 |
Why?
|
| Treatment Outcome | 17 | 2025 | 8270 | 0.660 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 244 | 0.610 |
Why?
|
| Intracranial Thrombosis | 3 | 2022 | 29 | 0.500 |
Why?
|
| Milrinone | 1 | 2014 | 6 | 0.490 |
Why?
|
| Headache Disorders, Primary | 1 | 2014 | 3 | 0.490 |
Why?
|
| Nicardipine | 1 | 2014 | 7 | 0.490 |
Why?
|
| Vasospasm, Intracranial | 1 | 2014 | 35 | 0.470 |
Why?
|
| Vasoconstriction | 1 | 2014 | 92 | 0.470 |
Why?
|
| Retrospective Studies | 15 | 2024 | 9203 | 0.470 |
Why?
|
| Mechanical Thrombolysis | 1 | 2014 | 16 | 0.460 |
Why?
|
| Vasodilator Agents | 1 | 2014 | 145 | 0.460 |
Why?
|
| Carotid Stenosis | 5 | 2025 | 117 | 0.450 |
Why?
|
| Catheters | 2 | 2024 | 85 | 0.450 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 197 | 0.440 |
Why?
|
| Humans | 40 | 2025 | 89924 | 0.430 |
Why?
|
| Venous Thrombosis | 3 | 2022 | 256 | 0.410 |
Why?
|
| Male | 21 | 2025 | 42657 | 0.390 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2024 | 147 | 0.390 |
Why?
|
| Heroin Dependence | 1 | 2011 | 14 | 0.390 |
Why?
|
| Leukoencephalopathies | 1 | 2011 | 16 | 0.390 |
Why?
|
| Heroin | 1 | 2011 | 11 | 0.380 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2011 | 59 | 0.370 |
Why?
|
| Middle Aged | 16 | 2025 | 26132 | 0.370 |
Why?
|
| Aged | 14 | 2025 | 19240 | 0.370 |
Why?
|
| Female | 21 | 2025 | 46571 | 0.360 |
Why?
|
| Neurosurgical Procedures | 3 | 2024 | 243 | 0.340 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 6780 | 0.320 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 841 | 0.310 |
Why?
|
| Intracranial Hemorrhages | 3 | 2024 | 130 | 0.300 |
Why?
|
| Carotid Artery, Internal, Dissection | 2 | 2024 | 23 | 0.290 |
Why?
|
| Adult | 10 | 2024 | 26810 | 0.280 |
Why?
|
| Angioplasty | 4 | 2013 | 70 | 0.270 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2024 | 173 | 0.250 |
Why?
|
| Vertebral Artery Dissection | 1 | 2024 | 14 | 0.240 |
Why?
|
| Carotid Artery, Internal | 1 | 2025 | 69 | 0.240 |
Why?
|
| Radial Artery | 1 | 2024 | 33 | 0.230 |
Why?
|
| Angiofibroma | 1 | 2023 | 4 | 0.210 |
Why?
|
| Computed Tomography Angiography | 1 | 2024 | 154 | 0.210 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2023 | 47 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2023 | 110 | 0.200 |
Why?
|
| Anticoagulants | 2 | 2024 | 431 | 0.200 |
Why?
|
| Dabigatran | 1 | 2022 | 25 | 0.200 |
Why?
|
| Hospital Mortality | 1 | 2024 | 408 | 0.200 |
Why?
|
| Cerebrovascular Disorders | 2 | 2013 | 145 | 0.190 |
Why?
|
| Reimbursement, Incentive | 1 | 2021 | 37 | 0.190 |
Why?
|
| Head Injuries, Penetrating | 1 | 2022 | 55 | 0.190 |
Why?
|
| Transportation of Patients | 1 | 2021 | 34 | 0.190 |
Why?
|
| Fee-for-Service Plans | 1 | 2021 | 30 | 0.190 |
Why?
|
| Warfarin | 1 | 2022 | 104 | 0.190 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 466 | 0.180 |
Why?
|
| Health Expenditures | 1 | 2021 | 90 | 0.180 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 102 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 160 | 0.170 |
Why?
|
| Health Care Costs | 1 | 2021 | 236 | 0.170 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 357 | 0.160 |
Why?
|
| Brain | 2 | 2024 | 2304 | 0.160 |
Why?
|
| Cerebral Infarction | 2 | 2024 | 72 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 2 | 2012 | 341 | 0.150 |
Why?
|
| Young Adult | 4 | 2015 | 6408 | 0.150 |
Why?
|
| Tissue and Organ Procurement | 1 | 2022 | 359 | 0.150 |
Why?
|
| Maxillary Artery | 1 | 2017 | 3 | 0.140 |
Why?
|
| Ankylosis | 1 | 2017 | 4 | 0.140 |
Why?
|
| Enbucrilate | 1 | 2017 | 7 | 0.140 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2017 | 21 | 0.140 |
Why?
|
| Chicago | 1 | 2021 | 1431 | 0.140 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2014 | 36 | 0.120 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 11 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2017 | 395 | 0.120 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2012 | 18 | 0.110 |
Why?
|
| Early Medical Intervention | 1 | 2012 | 20 | 0.100 |
Why?
|
| Cerebral Veins | 1 | 2012 | 31 | 0.100 |
Why?
|
| Cerebral Revascularization | 1 | 2012 | 28 | 0.100 |
Why?
|
| Hypolipidemic Agents | 1 | 2012 | 99 | 0.100 |
Why?
|
| Risk Factors | 6 | 2022 | 5554 | 0.100 |
Why?
|
| Dysarthria | 1 | 2011 | 6 | 0.100 |
Why?
|
| Smoke | 1 | 2011 | 27 | 0.100 |
Why?
|
| Nystagmus, Pathologic | 1 | 2011 | 35 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 124 | 0.100 |
Why?
|
| Inpatients | 2 | 2023 | 312 | 0.090 |
Why?
|
| Intracranial Hypertension | 1 | 2012 | 58 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 192 | 0.090 |
Why?
|
| Heparin | 1 | 2012 | 185 | 0.090 |
Why?
|
| Hemorrhage | 2 | 2024 | 287 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2012 | 905 | 0.090 |
Why?
|
| Hematoma | 1 | 2011 | 108 | 0.090 |
Why?
|
| Adolescent | 1 | 2023 | 9339 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1607 | 0.090 |
Why?
|
| Cerebellum | 1 | 2011 | 250 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2024 | 4325 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 254 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1054 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2014 | 2887 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 1352 | 0.070 |
Why?
|
| Medical Audit | 1 | 2006 | 39 | 0.070 |
Why?
|
| Computers | 1 | 2006 | 111 | 0.060 |
Why?
|
| Texas | 1 | 2006 | 116 | 0.060 |
Why?
|
| Forecasting | 1 | 2006 | 304 | 0.060 |
Why?
|
| Administration, Intravenous | 1 | 2024 | 56 | 0.060 |
Why?
|
| Basilar Artery | 1 | 2023 | 42 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2024 | 159 | 0.050 |
Why?
|
| Device Removal | 1 | 2024 | 168 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2024 | 222 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 179 | 0.050 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2022 | 10 | 0.050 |
Why?
|
| Injections, Intra-Arterial | 2 | 2012 | 32 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2012 | 238 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 2 | 2013 | 182 | 0.050 |
Why?
|
| Resuscitation | 1 | 2022 | 111 | 0.050 |
Why?
|
| Reimbursement Mechanisms | 1 | 2021 | 41 | 0.050 |
Why?
|
| Cost Savings | 1 | 2021 | 70 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 381 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2022 | 666 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3470 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2006 | 2327 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 427 | 0.040 |
Why?
|
| Algorithms | 1 | 2006 | 1908 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 1134 | 0.040 |
Why?
|
| Child | 2 | 2022 | 7242 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 888 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 3040 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 3680 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2013 | 28 | 0.030 |
Why?
|
| Intracranial Embolism | 1 | 2013 | 29 | 0.030 |
Why?
|
| Early Ambulation | 1 | 2013 | 25 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 5357 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2013 | 116 | 0.030 |
Why?
|
| Endarterectomy, Carotid | 1 | 2012 | 74 | 0.030 |
Why?
|
| Systole | 1 | 2011 | 115 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 300 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 416 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 275 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 846 | 0.020 |
Why?
|
| Reoperation | 1 | 2012 | 604 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 720 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 380 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2012 | 258 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7102 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 476 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1731 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1469 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2677 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 27526 | 0.010 |
Why?
|